000			02241 a2200577 4500
005			20250515083104.0
264		0	_c20070925
008			200709s 0 0 eng d
022			_a1078-0432
024	7		_a10.1158/1078-0432.CCR-07-0560 _2doi
040			_aNLM _beng _cNLM
100	1		_aRiely, Gregory J
245	0	0	_aProspective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus. _h[electronic resource]
260			_bClinical cancer research : an official journal of the American Association for Cancer Research _cSep 2007
300			_a5150-5 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdiagnostic imaging
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aErlotinib Hydrochloride
650	0	4	_aEverolimus
650	0	4	_aFemale
650	0	4	_aFluorodeoxyglucose F18
650	0	4	_aGefitinib
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xdiagnostic imaging
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPositron-Emission Tomography
650	0	4	_aProspective Studies
650	0	4	_aProtein Kinase Inhibitors _xtherapeutic use
650	0	4	_aQuinazolines _xtherapeutic use
650	0	4	_aSirolimus _xadministration & dosage
650	0	4	_aTomography, X-Ray Computed
700	1		_aKris, Mark G
700	1		_aZhao, Binsheng
700	1		_aAkhurst, Tim
700	1		_aMilton, Daniel T
700	1		_aMoore, Erin
700	1		_aTyson, Leslie
700	1		_aPao, William
700	1		_aRizvi, Naiyer A
700	1		_aSchwartz, Lawrence H
700	1		_aMiller, Vincent A
773	0		_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 13 _gno. 17 _gp. 5150-5
856	4	0	_uhttps://doi.org/10.1158/1078-0432.CCR-07-0560 _zAvailable from publisher's website
999			_c17314461 _d17314461